Congratulations to @Argerie Guevara (CBE’23) for taking the thesis option in her undergraduate research and passing it with unanimous consensus today. Her thesis was titled, “PLGA nanoparticles formulations loaded with antibiotics induce sustained and controlled antibiotics release for prolonged antibacterial action against MRSA, and Pseudomonas aeruginosa FRD1,” and is currently being peer-reviewed for publication. Argerie is currently pursuing a PhD in Bioengineering at the Boston University in Boston, MA.
Medical Technology Enterprise Consortium’s (MTEC) 8th Annual Meeting- Richmond, VA (May 23-24, 2023) »
May 01
Argerie Guevara (CBE’23) Successfully Defends her Undergraduate Thesis
Categories:
antibiotics, Antimicrobial, Berthiaume Institute for Precision Health, multidrug resistance, Uncategorized
by Prakash
This post has no tag
Recent Posts
- Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL) August 30, 2024
- Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa August 21, 2024
- Precision Health and Diagnostics Session Chair at Techconnect World Innovation Conference (2024) June 19, 2024
- MTEC Annual meeting in Baltimore MD (May 24, 2024) May 24, 2024
- Nallathamby Lab’s Kevin Armknecht is Invited to Present at the Midwest Microscopy and Microanalysis Workshop 2024 May 7, 2024
Archives
Categories
NIH Funding Opportunities
- Alcohol Health Services Research (R34 Clinical Trial Optional) November 27, 2024Funding Opportunity PAR-25-192 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are […]
- Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments November 27, 2024Notice NOT-CA-25-012 from the NIH Guide for Grants and Contracts
- NHLBI Announces Plan to Fund a Second Examination Cycle for the Risk Underlying Rural Areas Longitudinal (RURAL) Heart and Lung Study November 27, 2024Notice NOT-HL-24-034 from the NIH Guide for Grants and Contracts
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) November 27, 2024Funding Opportunity PAR-25-193 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are […]
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) November 27, 2024Funding Opportunity PA-25-163 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications […]
- Alcohol Health Services Research (R01 Clinical Trial Optional) November 27, 2024Funding Opportunity PA-25-245 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are […]
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) November 26, 2024Funding Opportunity PAR-25-134 from the NIH Guide for Grants and Contracts. The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutionsis to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the […]
- Notice of Participation in NOT-CA-25-003, Notice of Special Interest (NOSI): Implementation Science for Climate Change and Health November 26, 2024Notice NOT-MH-25-095 from the NIH Guide for Grants and Contracts
- Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required) November 26, 2024Funding Opportunity PAR-25-285 from the NIH Guide for Grants and Contracts. This R61/R33 concept complements NIMHs suite of clinical trial NOFOs by supporting feasibility and infrastructure development (R61) followed by well-powered clinical trials (R33) to test the effectiveness of system interventions and strategies for improving the organization, delivery, coordination, and clinical and functional outcomes of […]
- Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) November 26, 2024Funding Opportunity PAR-25-184 from the NIH Guide for Grants and Contracts. NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate information about the mechanisms underlying a disorder or an intervention response. As part of NIMHs Clinical Trial […]
Recent Comments